SalaryGuide
AboutPricingFor Employers

Marketing jobs

2 marketing jobs

WuXi AppTec logo
2 months ago

Digital Marketing and Operations Analyst

WuXi AppTec

USA (On-site)Other
WuXi AppTec logo
4 months ago

Digital Marketing and Operations Analyst

WuXi AppTec

USA (Unknown)

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

2 jobs
WuXi AppTec logo

Digital Marketing and Operations Analyst

WuXi AppTec

USA (On-site)

In-houseOtherMid level
2 months ago
WuXi AppTec logo

Digital Marketing and Operations Analyst

WuXi AppTec

USA (Unknown)

In-houseMid level
4 months ago
WuXi AppTec logo
WuXi AppTec

Digital Marketing and Operations Analyst

USA (On-site)

Salary Not AvailableMid LevelOther

Posted 2 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the end-to-end HubSpot-driven marketing operations workflow, ensuring campaign execution, data integrity, lead lifecycle, and sales handoff across marketing and sales platforms.

  • HubSpot & Salesforce lifecycle orchestration: lead capture, nurturing, qualification, and suppression with accurate handoff.
  • Campaign execution & optimization: landing pages, forms, emails, workflows, QA, scheduling, and performance tracking.
  • Data integrity & reporting: attribution, MQL/SQL progression, dashboards, and agile-driven delivery.

Job Description

Responsibilities

  • Partner with content teams to support campaign execution, tracking, and optimization.
  • Analyze content engagement performance, including gated vs. ungated strategies, nurturing effectiveness, and user behavior.
  • Identify underperforming campaigns or assets and provide data-driven recommendations for optimization.
  • Support website strategy execution, including campaign landing pages, form performance, and conversion optimization.
  • Analyze and improve technical and on-page SEO performance in collaboration with content and web teams.
  • Monitor user behavior and engagement data to inform digital experience improvements.
  • Execute email marketing campaigns in HubSpot, including email build, QA, scheduling, deployment, and performance tracking.
  • Support campaign execution across HubSpot tools, including forms, landing pages, workflows, lists, and campaigns.
  • Optimize email and inbound performance using engagement and conversion data (open rates, CTR, form conversion, lifecycle progression).
  • Monitor channel health and identify performance trends or degradation.
  • Apply data-driven improvements to messaging, segmentation, timing, and CTAs in alignment with established strategy.
  • Support execution of the lead lifecycle within HubSpot, including lead capture, nurturing, re-engagement, qualification, and suppression.
  • Ensure accurate lead handoff from HubSpot to Salesforce, including lifecycle stage updates, ownership assignment, and field mapping.
  • Monitor lead flow, routing, and status changes to ensure data accuracy and sales visibility.
  • Identify and flag issues impacting MQL/SQL progression, attribution, or reporting consistency.
  • Execute and maintain HubSpot workflows, automation, and lifecycle logic.
  • Support Salesforce-related marketing operations activities, including campaign member updates, lead status alignment, and reporting accuracy.
  • Manage assigned initiatives using an Agile approach, including task breakdown, prioritization, sprint-style execution, and delivery tracking.
  • Coordinate timelines, dependencies, and handoffs across marketing and sales.
  • Proactively identify execution risks and escalate issues to ensure on-time deliveryward?

Requirements

  • Bachelor’s degree in business, analytics, or a related field.
  • Strong attention to detail and operational discipline
  • Ability to manage multiple initiatives in a fast-paced environment
  • Comfort executing within defined strategies, workflows, and systems
  • Strong written and verbal communication skill

Preferred

  • Hands-on experience or strong exposure to HubSpot and Salesforce
  • Familiarity with lead lifecycle concepts, MQL/SQL definitions, and attribution
  • Exposure to Agile project management concepts or tools
  • Experience supporting reporting or dashboards in a marketing or revenue environment
WuXi AppTec logo

WuXi AppTec

WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside nearly 6,000 partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time. Learn more at www.wuxiapptec.com.

Founded in 2000
Shanghai, Guangdong, CHN
4.2K employees (110 in marketing)
www.wuxiapptec.com

Traffic Signals

Monthly Visitors
80.8K
Monthly Google Ads Budget
$16.4K
Traffic Source Mix
Search
43.5%
Direct
47.1%
Referral
7.7%
Social
0.9%
Paid
0.7%

Headcount Trend

Current headcount: ~4.2K

Marketing Team

Marketing Team Size
85 (2% of company)

Funding

Total Funding
$1.6B
Last Raise
$1.5B
Debt Financing, 10 years ago

Funding History

  • Mar 2016
    Debt Financing • $1.5B
  • Jul 2008
    Post IPO Equity • $63M
  • Feb 2007
    Series C • $17.3M

Recent News

WUXI APPTEC CO LTD UNSPON ADS EACH REP 1 ORD SHS(WUXAY.US)将于10月24日发布财报
Oct 20, 2025 • 富途牛牛
WuXi AppTec Implements Its First Interim Dividend Plan, Distributing RMB1.03 Billion in Cash Dividends
Sep 22, 2025 • MarketScreener
WuXi AppTec Co., Ltd. Implements First Interim Dividend Plan
Sep 22, 2025 • MarketScreener
WuXi AppTec Implements Its First Interim Dividend Plan, Distributing RMB1.03 Billion in Cash Dividends
Sep 22, 2025 • prnasia.com
WuXi AppTec Implements Its First Interim Dividend Plan, Distributing RMB1.03 Billion in Cash Dividends
Sep 22, 2025 • PR Newswire
WuXi AppTec shares rise on interim dividend announcement
Sep 21, 2025 • Investing.com
Hong Kong stocks hold steady as investors await signals from Trump-Xi call
Sep 19, 2025 • South China Morning Post
Bridging Innovation and Commercial Success: The Strategic Value of Integrated CRDMO Services
Sep 19, 2025 • EIN Presswire
WuXi AppTec's Enduring Strength: The CRDMO Model as a Foundation for Long-Term Growth
Sep 18, 2025 • EIN Presswire
Hong Kong stocks waver as investors await rate-cut news while US, China tout TikTok deal
Sep 16, 2025 • South China Morning Post
JPMorgan's Long Position In H Shares Of Wuxi Apptec Decreases
Sep 15, 2025 • Reuters
WuXi AppTec's New EU Batch Release Services: What This Means for European Biotech
Sep 15, 2025 • EIN Presswire
JPMorgan's long position in H shares of Wuxi Apptec decreases
Sep 15, 2025 • MarketScreener
Jpmorgan Chase & Co's long position in H shares of Wuxi Apptec increases to 6.71%, HKEX filing shows
Sep 12, 2025 • MarketScreener
BlackRock's long position in H shares of Wuxi Apptec decreases to 4.75%, HKEX filing shows
Sep 12, 2025 • MarketScreener
‘Pushing physics to the limit’: MGI’s DNA sequencers gaining in the market, BGI CEO says
Sep 11, 2025 • South China Morning Post
Citigroup's long position in Wuxi Apptec's H shares decreases to 4.84%, HKEX filing shows
Aug 20, 2025 • MarketScreener
Viral Vector Development Market to Reach USD 5.00 Billion at 18.84% CAGR by 2034
Aug 19, 2025 • BioSpace
Citigroup's short position in H-shares of Wuxi Apptec decreases to 1.95% on Aug 8 from 2.65% - HKEX
Aug 14, 2025 • MarketScreener
UBS Group AG's long position in H-shares of Wuxi Apptec increases to 7.26% on Aug 8 from 6.73% - HKEX
Aug 14, 2025 • MarketScreener
North America Clinical Trials Market Growth Trends Report 2025-2033 | Lengthy Clinical Trials, Rising Viral Disorders, Demand for New Treatments, and Government R&D Support - ResearchAndMarkets.com
Aug 8, 2025 • Business Wire
Global Cell and Gene Therapy Market to Grow at 23% CAGR Driven by R&D and Regulatory Support by 2030
Aug 7, 2025 • PharmiWeb
WuXi AppTec Named Constituent of the FTSE4Good Index Series for Third Consecutive Year
Aug 6, 2025 • PR Newswire
Cell Line Development Market Outlook Report 2025-2034: PromoCell, Novartis, Genscript Biotech, Sartorius, and Thermo Fisher Scientific Dominate the Industry
Aug 6, 2025 • Research and Markets
WuXi AppTec Named Constituent of the FTSE4Good Index Series for Third Consecutive Year
Aug 5, 2025 • Morningstar.com
Residual DNA Testing Global Market Forecast to 2030 | Novel Modalities, Emerging Markets Growth, Continuous Processing Integration, and Rising CRO/CDMO Outsourcing
Aug 5, 2025 • Research and Markets
China's Wuxi Apptec to raise $980 million via new shares to boost expansion
Jul 31, 2025 • MarketScreener
Hong Kong stocks slide to 2-week low on Fed rate decision and China manufacturing data
Jul 31, 2025 • South China Morning Post
WuXi AppTec Seeks HK$7.65 Billion via Share Sale; Shares Fall 5%
Jul 31, 2025 • MarketScreener
WuXi AppTec Plans to Raise $975 Million Via Share Placement
Jul 31, 2025 • MarketScreener
WuXi Biologics' Profit Guidance Signals Rebound In China's Drug Sector
Jul 31, 2025 • Benzinga.com
Wuxi AppTec raises US$981 mn in Hong Kong offer amid growing appetite for Chinese biotech
Jul 31, 2025 • South China Morning Post
Healthcare Analytical Testing Services Market is expected to generate a revenue of USD 9.56 Billion by 2031, Globally, at 11.20% CAGR: Verified Market Research®
Jul 31, 2025 • Verified Market Research
药明康德 (WUXIF) 2025 年第二季度财报电话会议摘要
Jul 30, 2025 • 富途牛牛
BlackRock's long position in H shares of Wuxi Apptec increases to 6.04% on July 18 - HKEX
Jul 23, 2025 • MarketScreener
BlackRock's long position in H-shares of Wuxi-Apptec increases to 5.57% on July 16 - HKEX
Jul 22, 2025 • MarketScreener
Citigroup's long position in H-shares of Wuxi Apptec increases to 6.12% on July 16 - HKEX
Jul 22, 2025 • MarketScreener
JPMorgan's long position in H-shares of Wuxi Apptec decreases to 8.92% on July 17 - HKEX
Jul 22, 2025 • MarketScreener
Pharma Contract Research Organization (CRO) Services Market to Cross USD 36.66 Billion in 2025, Expanding at a CAGR of 10.04%
Jul 18, 2025 • Precedence Research
药明康德走出风波 上半年净利润翻倍
Jul 17, 2025 • thebambooworks.com
Global Drug Discovery Services Market Expected to Expand at 15% CAGR Due to Chronic Diseases by 2030
Jul 17, 2025 • PharmiWeb
G-Protein Coupled Receptor (GPCR) Targeting Technologies Market on the Rise
Jul 16, 2025 • PR Newswire UK
JPMorgan's Long Position In H-Shares Of Wuxi Apptec Increases To 9.24% On July 11 - HKEX
Jul 16, 2025 • Reuters
JPMorgan's long position in H-shares of Wuxi Apptec increases to 9.24% on July 11 - HKEX
Jul 16, 2025 • MarketScreener
Hong Kong stocks cap weekly gain on earnings optimism; Wuxi AppTec rallies
Jul 11, 2025 • South China Morning Post
US-China Tensions Cause Delay in Chinese Drug Research Projects, Sources Say
Jun 18, 2025 • MarketScreener
WuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction Targets
Jun 18, 2025 • prnasia.com
China pharma projects disrupted by Sino-US tensions
Jun 17, 2025 • Reuters
WuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction Targets
Jun 17, 2025 • Morningstar.com
WuXi AppTec Recognized by Extel 2025 Asia Executive Team Rankings with Top Honors
Jun 16, 2025 • prnasia.com
WuXi AppTec's Trustee Buys Back HK$1.5 Billion of Shares for Incentive Scheme
Jun 16, 2025 • MarketScreener
Hong Kong stocks fall on US trade threats and interest rate uncertainty
Jun 12, 2025 • South China Morning Post
CMO/CDMO Market Expected to Grow at 3.1% CAGR Through 2035
Jun 11, 2025 • EIN Presswire
US Small Molecule Innovator API CDMO Market: Strategic Partnerships and FDA Approvals Propel Expansion
Jun 10, 2025 • Research and Markets
Revolutionizing Drug Discovery: DNA-Encoded Libraries Market Set to Double Growth by 2030 with a 13.51% CAGR
Jun 9, 2025 • Research and Markets
The Risks of Foreign Investment in U.S. Life Sciences Companies — Why Founders Should Take Heed
Jun 7, 2025 • International Business Times
Short sellers targeting global consumer and luxury brands, says Hazeltree
Jun 6, 2025 • Hedgeweek
JPMorgan Chase & Co's Long Position In Wuxi Apptec H-Shares Increases To 7.12% On May 30 - HKEX
Jun 5, 2025 • MarketScreener
Biopharmaceutical CMOs Market 2025–2034: Key Insights on Size, Growth Drivers, Trends & Competitive Landscape
Jun 5, 2025 • EIN Presswire
Global Nutraceutical CDMO Market: Outsourcing Opportunities and 8% CAGR Growth by 2030
Jun 4, 2025 • PharmiWeb
Before embodied intelligent robots become a reality, there are still these challenges to overcome | Focus Analysis
Jun 2, 2025 • 36kr.com
Hong Kong stocks jump after US court blocks Trump’s tariffs in boon for trade
May 29, 2025 • South China Morning Post
Global Acetyl Serine Market Set for Robust Growth Amid Rising Demand in Pharmaceutical and Nutraceutical Applications
May 23, 2025 • EIN Presswire
Hong Kong stocks complete sixth week of gains on upbeat China outlook
May 23, 2025 • South China Morning Post
Biopharmaceuticals Market Share 2025: Risks, Returns, and Emerging Sectors to 2032
May 14, 2025 • PRLog
Contract Clinical Research Organization Market Expected to Surpass USD 165.56 Billion by 2032, CAGR of 9.5%
May 9, 2025 • EIN Presswire
WuXi AppTec’s Chairman Tops Pay Rankings Among Chinese Mainland-Listed Firms
May 8, 2025 • Yicai Global
Health Industry Impact Report Q1, 2025: 55% of Healthcare Organisations Delay Mental Health Investments Due to Tariff-Driven Supply Chain Disruptions
May 7, 2025 • Research and Markets
Cell and Gene Therapy Biomanufacturing Industry Outlook 2025-2035: Rising Demand for Personalized Medicine and Regulatory Fast-Tracking Fuel Global Growth
May 7, 2025 • Research and Markets
G-Protein Coupled Receptor (GPCR) Targeting Technologies and Markets Forecast to 2029: A $6.1 Billion Industry Opportunity
May 6, 2025 • Research and Markets
Hong Kong stocks surge on trade-talk optimism, US gains by tech giants
May 2, 2025 • South China Morning Post
WuXi AppTec reports Q1 results
Apr 29, 2025 • Seeking Alpha
Cell Therapy Manufacturing Industry Forecast to 2035: High Demand for T-Cell Therapies to Generate 45% of Clinical Need by 2035 - ResearchAndMarkets.com
Apr 8, 2025 • Business Wire
Mendota Heights med tech company to lay off 124 workers after acquisition
Apr 8, 2025 • Twin Cities
Drug Discovery Services Market Global Forecast Report 2025-2030: Increasing Reliance on Outsourcing due to Costly In-House Drug Development
Apr 8, 2025 • Research and Markets
Medtech firm NAMSA to lay off more than 50 in St. Paul after acquisition
Apr 8, 2025 • Star Tribune
WuXi AppTec's Changzhou and Taixing API Sites Successfully Pass FDA Inspections
Apr 1, 2025 • PR Newswire
Viral Vector & Plasmid DNA Manufacturing Market to Reach USD 24.6 Billion by 2032
Mar 31, 2025 • PRLog
Biopharmaceutical CMO and CRO Market Analysis 2024 – 2033 | By Key Players, Product Type, Application and Region
Mar 26, 2025 • EIN Presswire
Drug Discovery Services Market worth US$27.23 billion in 2030 with 10.7% CAGR | MarketsandMarkets™
Mar 25, 2025 • PR Newswire
Drug Discovery Services Market worth US$27.23 billion in 2030 with 10.7% CAGR | MarketsandMarkets™
Mar 25, 2025 • prnewswire.co.uk
Global Clinical Trial Support Services Market Report 2025: Trends, Size, Key Players & Future Outlook
Mar 25, 2025 • EIN Presswire
Trump-era and RFK Jr Administration Drug Development & Outsourcing Impact Report 2025: Insights from 200 US and EU Biopharmaceutical Professionals - ResearchAndMarkets.com
Mar 20, 2025 • Business Wire
WuXi AppTec offers rosy 2025 guidance despite threat of US-China trade tensions
Mar 18, 2025 • Fierce Pharma
WuXi AppTec Shares Jump After Proposed Special Dividend, Share Buyback
Mar 18, 2025 • MarketScreener
WuXi AppTec's US revenue growth continues to dip in post-Biosecure environment
Mar 17, 2025 • Endpoints News
Pharmaceutical Analytical Testing Outsourcing Market to Expand at 8.81% CAGR, Expected to Hit USD 9.74 Billion by 2032
Mar 17, 2025 • EIN Presswire
DIARY-Hong Kong corporate earnings week ahead
Mar 14, 2025 • MarketScreener
global preclinical medical device testing services market share analysis
Mar 12, 2025 • PharmiWeb.com
Viral Vector Manufacturing Market Anticipated to Reach USD 6.5 Billion, at a Notable 11.94% CAGR by 2034
Mar 11, 2025 • EIN Presswire
medical device analytical testing outsourcing
Mar 11, 2025 • PharmiWeb.com
Pharmaceutical CMO Market is Anticipated to Reach $220.0 Billion by 2035, Growing at a CAGR of 4.61%
Mar 11, 2025 • EIN Presswire
Clinical Trials Market Forecast Report 2025: A $99.25 Billion Industry by 2033, Driven by Acceptance of Decentralized Experiments, Shift Towards Personalized Medicine, Demand for Effective Treatments
Mar 10, 2025 • GlobeNewswire News Room
Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight
Mar 5, 2025 • GlobeNewswire News Room
Dermatology CRO Market to Hit USD 8.6 Billion by 2032, Growing at 6.7% CAGR
Feb 28, 2025 • EIN Presswire
Global Clinical Trial Market Overview to Reach USD 184.61 Billion by 2034 at a 5.7% of CAGR
Feb 27, 2025 • PharmiWeb.com
G-Protein Coupled Receptors Market Size to Capture $6.37 Billion by 2034
Feb 26, 2025 • BioSpace
U.S. Medical Device Outsourcing Market Size to Reach USD 94.80 Bn By 2034
Feb 25, 2025 • BioSpace
$5.37 Bn G-Protein Coupled Receptors Market Trends, Opportunity, and Forecasts, 2020-2024 & 2025-2030: AI, Cryo-EM, and Precision Medicine Propel Growth, Innovations in Cancer, Cardio, & Neurological
Feb 25, 2025 • GlobeNewswire News Room
U.S. Cell And Gene Therapy CDMO Market Size to Hit USD 33.24 Bn by 2034
Feb 25, 2025 • BioSpace